Degarelix Acetate Powder
NDC Package 14799-3003-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Degarelix Acetate powders is degarelix is used to treat advanced prostate cancer in men. This formulation utilizes a powder delivery system. Marketed by Zhejiang Supor Pharmaceuticals Co., Ltd, this product is identified by NDC 14799-3003.

Identification & Billing

NDC Package Code
14799-3003-3
Package Description
50 g in 1 BAG
Product Code
14799-3003
11-Digit Billing Format
14799300303

Clinical Specifications

Proprietary Name
Degarelix Acetate
Non-Proprietary Name
Degarelix Acetate
Substance Name
Argipressin
Dosage Form
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s)
ARGIPRESSIN 1 g/g
Usage Information
Degarelix is used to treat advanced prostate cancer in men. It is not a cure. Most types of prostate cancer need the male hormone testosterone to grow and spread. Degarelix works by reducing the amount of testosterone that the body makes. This helps slow or stop the growth of cancer cells.

Regulatory & Marketing

Labeler Name
Zhejiang Supor Pharmaceuticals Co., Ltd
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
06-15-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (14799-3003). Click a package code to view its specific billing and regulatory data.

14799-3003-1
500 g in 1 BAG
14799-3003-2
100 g in 1 BAG
14799-3003-4
1 g in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 14799-3003-3 identifies a specific commercial package of 50 g in 1 bag of Degarelix Acetate (UNFINISHED drug), a bulk ingredient labeled by Zhejiang Supor Pharmaceuticals Co., Ltd. This powder is formulated for use and contains argipressin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zhejiang Supor Pharmaceuticals Co., Ltd on June 15, 2022. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Degarelix is used to treat advanced prostate cancer in men. It is not a cure. Most types of prostate cancer need the male hormone testosterone to grow and spread. Degarelix works by reducing the amount of testosterone that the body makes. This helps slow or stop the growth of cancer cells.

How is this Zhejiang Supor Pharmaceuticals Co., Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 14799300303. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
14799-3003-3
11-Digit CMS (5-4-2)
14799-3003-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.